US Stock MarketDetailed Quotes

MCRB Seres Therapeutics

Watchlist
  • 9.940
  • +0.210+2.16%
Trading Apr 24 10:26 ET
86.66MMarket Cap497.00P/E (TTM)

Seres Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-26.63%-148.61M
18.14%-38.88M
41.47%-34.68M
-160.33%-39.81M
53.99%-35.24M
48.71%-117.35M
10.20%-47.5M
0.55%-59.26M
232.24%65.98M
-15.26%-76.58M
Net income from continuing operations
100.12%136K
62.09%-15.64M
285.51%88.78M
-170.61%-32.87M
43.61%-40.13M
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
Operating gains losses
-174,163.38%-123.59M
105.85%24K
-12,089.33%-123.36M
---130K
---123K
--71K
---410K
---1.01M
----
----
Depreciation and amortization
-12.41%5.47M
-33.52%1.09M
-16.63%1.4M
-7.01%1.42M
11.36%1.56M
-5.82%6.24M
0.31%1.63M
-3.61%1.68M
-9.38%1.53M
-10.83%1.4M
Other non cash items
-29.83%10.64M
-29.08%2.01M
42.38%2.91M
-35.21%2.87M
-51.26%2.86M
118.78%15.17M
14.30%2.83M
-19.30%2.04M
158.79%4.43M
2,627.44%5.86M
Change In working capital
-11.08%-65.51M
-95.76%-30.13M
57.90%-9.59M
-1,036.41%-16.64M
52.67%-9.15M
-220.68%-58.98M
-442.13%-15.39M
-120.19%-22.79M
-132.84%-1.46M
-13.76%-19.34M
-Change in receivables
176.16%6.61M
-125.27%-2.07M
300.05%18.6M
-47.94%-11.18M
--1.26M
---8.67M
--8.18M
---9.3M
---7.56M
--0
-Change in inventory
-13.99%-33.8M
--0
20.78%-10.45M
-106.44%-11.02M
---12.33M
---29.65M
---11.12M
---13.19M
---5.34M
--0
-Change in prepaid assets
103.39%987K
102.30%726K
-110.70%-2.27M
-451.40%-1.88M
44.74%4.41M
-131.16%-29.12M
-10,642.67%-31.63M
60.97%-1.08M
108.49%535K
179.25%3.04M
-Change in payables and accrued expense
-777.09%-28.84M
-224.48%-26.81M
-100.98%-9.06M
-3.83%9.68M
88.40%-2.65M
-23.09%4.26M
267.81%21.54M
-63.31%-4.51M
-20.12%10.07M
-124.83%-22.84M
-Change in other current liabilities
-188.53%-6.34M
-250.89%-1.97M
-99.05%-2.11M
-300.59%-2.04M
-225.37%-218K
47.73%-2.2M
17.72%-562K
23.88%-1.06M
18.14%-510K
95.55%-67K
-Change in other working capital
-164.39%-4.12M
--0
-168.10%-4.32M
-113.91%-187K
-27.39%379K
189.86%6.41M
-84.51%-1.8M
284.03%6.34M
210.53%1.34M
134.96%522K
Cash from discontinued investing activities
Operating cash flow
-26.63%-148.61M
18.14%-38.88M
41.47%-34.68M
-160.33%-39.81M
53.99%-35.24M
48.71%-117.35M
10.20%-47.5M
0.55%-59.26M
232.24%65.98M
-15.26%-76.58M
Investing cash flow
Cash flow from continuing investing activities
1,244.67%142.29M
89.74%-90K
7,954.37%141.14M
-87.62%1.3M
-102.26%-62K
-87.16%10.58M
-114.80%-877K
-104.48%-1.8M
-55.05%10.52M
-78.89%2.74M
Net PPE purchase and sale
95.24%-380K
89.74%-90K
92.82%-129K
91.97%-99K
98.48%-62K
18.80%-7.98M
74.66%-877K
-44.11%-1.8M
43.00%-1.23M
-37.90%-4.07M
Net business purchase and sale
--141.27M
--0
----
----
----
--0
--0
----
----
----
Net investment purchase and sale
--0
--0
--0
--0
--0
-79.88%18.56M
--0
--0
-54.03%11.75M
-57.25%6.81M
Net other investing changes
--1.4M
--0
--0
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
1,244.67%142.29M
89.74%-90K
7,954.37%141.14M
-87.62%1.3M
-102.26%-62K
-87.16%10.58M
-114.80%-877K
-104.48%-1.8M
-55.05%10.52M
-78.89%2.74M
Financing cash flow
Cash flow from continuing financing activities
-226.03%-90.37M
-72.98%1.74M
-7,783.37%-110.87M
0
231.72%18.76M
-44.67%71.71M
39.85%6.43M
-98.53%1.44M
44,651.54%58.18M
-78.93%5.66M
Net issuance payments of debt
-353.19%-127.91M
--0
---127.91M
----
----
96.58%50.52M
--0
--0
----
----
Net common stock issuance
29.58%23.53M
-72.98%1.74M
--3.38M
--0
334.28%18.41M
-82.05%18.16M
450.43%6.43M
--0
--7.49M
--4.24M
Proceeds from stock option exercised by employees
-83.92%487K
--0
-90.71%134K
--0
-75.09%353K
10.71%3.03M
--0
10.49%1.44M
29.23%168K
23.32%1.42M
Net other financing activities
--13.52M
--0
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-226.03%-90.37M
-72.98%1.74M
-7,783.37%-110.87M
--0
231.72%18.76M
-44.67%71.71M
39.85%6.43M
-98.53%1.44M
44,651.54%58.18M
-78.93%5.66M
Net cash flow
Beginning cash position
-20.48%136.15M
-56.94%76.7M
-65.88%81.11M
16.10%119.61M
-20.48%136.15M
-8.93%171.22M
-16.61%178.1M
76.07%237.71M
-36.16%103.03M
-8.93%171.22M
Current changes in cash
-175.72%-96.69M
11.23%-37.24M
92.61%-4.41M
-128.59%-38.51M
75.75%-16.54M
-108.91%-35.07M
1.00%-41.95M
-175.86%-59.61M
610.76%134.68M
-156.11%-68.19M
Effect of exchange rate changes
-150.00%-1K
---1K
--0
----
----
300.00%2K
--0
150.00%1K
----
----
End cash Position
-71.02%39.46M
-71.02%39.46M
-56.94%76.7M
-65.88%81.11M
16.10%119.61M
-20.48%136.15M
-20.48%136.15M
-16.61%178.1M
76.07%237.71M
-36.16%103.03M
Free cash flow
-18.88%-148.99M
19.44%-38.97M
42.98%-34.81M
-161.64%-39.91M
56.23%-35.3M
47.48%-125.33M
14.16%-48.38M
-0.37%-61.05M
224.38%64.75M
-16.22%-80.65M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -26.63%-148.61M18.14%-38.88M41.47%-34.68M-160.33%-39.81M53.99%-35.24M48.71%-117.35M10.20%-47.5M0.55%-59.26M232.24%65.98M-15.26%-76.58M
Net income from continuing operations 100.12%136K62.09%-15.64M285.51%88.78M-170.61%-32.87M43.61%-40.13M54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M
Operating gains losses -174,163.38%-123.59M105.85%24K-12,089.33%-123.36M---130K---123K--71K---410K---1.01M--------
Depreciation and amortization -12.41%5.47M-33.52%1.09M-16.63%1.4M-7.01%1.42M11.36%1.56M-5.82%6.24M0.31%1.63M-3.61%1.68M-9.38%1.53M-10.83%1.4M
Other non cash items -29.83%10.64M-29.08%2.01M42.38%2.91M-35.21%2.87M-51.26%2.86M118.78%15.17M14.30%2.83M-19.30%2.04M158.79%4.43M2,627.44%5.86M
Change In working capital -11.08%-65.51M-95.76%-30.13M57.90%-9.59M-1,036.41%-16.64M52.67%-9.15M-220.68%-58.98M-442.13%-15.39M-120.19%-22.79M-132.84%-1.46M-13.76%-19.34M
-Change in receivables 176.16%6.61M-125.27%-2.07M300.05%18.6M-47.94%-11.18M--1.26M---8.67M--8.18M---9.3M---7.56M--0
-Change in inventory -13.99%-33.8M--020.78%-10.45M-106.44%-11.02M---12.33M---29.65M---11.12M---13.19M---5.34M--0
-Change in prepaid assets 103.39%987K102.30%726K-110.70%-2.27M-451.40%-1.88M44.74%4.41M-131.16%-29.12M-10,642.67%-31.63M60.97%-1.08M108.49%535K179.25%3.04M
-Change in payables and accrued expense -777.09%-28.84M-224.48%-26.81M-100.98%-9.06M-3.83%9.68M88.40%-2.65M-23.09%4.26M267.81%21.54M-63.31%-4.51M-20.12%10.07M-124.83%-22.84M
-Change in other current liabilities -188.53%-6.34M-250.89%-1.97M-99.05%-2.11M-300.59%-2.04M-225.37%-218K47.73%-2.2M17.72%-562K23.88%-1.06M18.14%-510K95.55%-67K
-Change in other working capital -164.39%-4.12M--0-168.10%-4.32M-113.91%-187K-27.39%379K189.86%6.41M-84.51%-1.8M284.03%6.34M210.53%1.34M134.96%522K
Cash from discontinued investing activities
Operating cash flow -26.63%-148.61M18.14%-38.88M41.47%-34.68M-160.33%-39.81M53.99%-35.24M48.71%-117.35M10.20%-47.5M0.55%-59.26M232.24%65.98M-15.26%-76.58M
Investing cash flow
Cash flow from continuing investing activities 1,244.67%142.29M89.74%-90K7,954.37%141.14M-87.62%1.3M-102.26%-62K-87.16%10.58M-114.80%-877K-104.48%-1.8M-55.05%10.52M-78.89%2.74M
Net PPE purchase and sale 95.24%-380K89.74%-90K92.82%-129K91.97%-99K98.48%-62K18.80%-7.98M74.66%-877K-44.11%-1.8M43.00%-1.23M-37.90%-4.07M
Net business purchase and sale --141.27M--0--------------0--0------------
Net investment purchase and sale --0--0--0--0--0-79.88%18.56M--0--0-54.03%11.75M-57.25%6.81M
Net other investing changes --1.4M--0--0----------------------------
Cash from discontinued investing activities
Investing cash flow 1,244.67%142.29M89.74%-90K7,954.37%141.14M-87.62%1.3M-102.26%-62K-87.16%10.58M-114.80%-877K-104.48%-1.8M-55.05%10.52M-78.89%2.74M
Financing cash flow
Cash flow from continuing financing activities -226.03%-90.37M-72.98%1.74M-7,783.37%-110.87M0231.72%18.76M-44.67%71.71M39.85%6.43M-98.53%1.44M44,651.54%58.18M-78.93%5.66M
Net issuance payments of debt -353.19%-127.91M--0---127.91M--------96.58%50.52M--0--0--------
Net common stock issuance 29.58%23.53M-72.98%1.74M--3.38M--0334.28%18.41M-82.05%18.16M450.43%6.43M--0--7.49M--4.24M
Proceeds from stock option exercised by employees -83.92%487K--0-90.71%134K--0-75.09%353K10.71%3.03M--010.49%1.44M29.23%168K23.32%1.42M
Net other financing activities --13.52M--0--------------------------------
Cash from discontinued financing activities
Financing cash flow -226.03%-90.37M-72.98%1.74M-7,783.37%-110.87M--0231.72%18.76M-44.67%71.71M39.85%6.43M-98.53%1.44M44,651.54%58.18M-78.93%5.66M
Net cash flow
Beginning cash position -20.48%136.15M-56.94%76.7M-65.88%81.11M16.10%119.61M-20.48%136.15M-8.93%171.22M-16.61%178.1M76.07%237.71M-36.16%103.03M-8.93%171.22M
Current changes in cash -175.72%-96.69M11.23%-37.24M92.61%-4.41M-128.59%-38.51M75.75%-16.54M-108.91%-35.07M1.00%-41.95M-175.86%-59.61M610.76%134.68M-156.11%-68.19M
Effect of exchange rate changes -150.00%-1K---1K--0--------300.00%2K--0150.00%1K--------
End cash Position -71.02%39.46M-71.02%39.46M-56.94%76.7M-65.88%81.11M16.10%119.61M-20.48%136.15M-20.48%136.15M-16.61%178.1M76.07%237.71M-36.16%103.03M
Free cash flow -18.88%-148.99M19.44%-38.97M42.98%-34.81M-161.64%-39.91M56.23%-35.3M47.48%-125.33M14.16%-48.38M-0.37%-61.05M224.38%64.75M-16.22%-80.65M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Salesforce
CRM
261.740
Broadcom
AVGO
183.725
Qualcomm
QCOM
145.685
4
Oracle
ORCL
136.090
5
Advanced Micro Devices
AMD
93.021
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀